Tema Oncology ETF CANC
42.13 USD -0.55 (-1.29%)
Nov 11, 2026, 11:01 AM EST
42.01 Day range 42.46
32.81 52-week range 47.00
- YTD
- +21.34%
- 1 year
- +28.21%
News
benzinga.com EXCLUSIVE: AI, Genomics Could Fuel Biotech ETF Re-Rating as Health Care Trades at Discount, Says Expert AI and genomics could fuel a biotech ETF re-rating as health care trades at a discount, says Dr. David Song, MD, PhD.
benzinga.com Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 2026. COGT stock rises on the news.
benzinga.com The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly Large pharma companies are facing severe patent cliffs, where blockbuster drugs lose exclusivity and revenue plummets.
